1,3-dipropylxanthine has been researched along with denbufylline in 1 studies
Studies (1,3-dipropylxanthine) | Trials (1,3-dipropylxanthine) | Recent Studies (post-2010) (1,3-dipropylxanthine) | Studies (denbufylline) | Trials (denbufylline) | Recent Studies (post-2010) (denbufylline) |
---|---|---|---|---|---|
26 | 0 | 0 | 39 | 2 | 1 |
Protein | Taxonomy | 1,3-dipropylxanthine (IC50) | denbufylline (IC50) |
---|---|---|---|
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | 0.0851 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | 0.0851 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | 0.0851 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 0.0851 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hasegawa, T; Iwasaki, N; Konno, K; Kurita, M; Miyamoto, K; Ohshima, T; Sakai, R; Sanae, F; Takagi, K; Yamamoto, Y | 1 |
1 other study(ies) available for 1,3-dipropylxanthine and denbufylline
Article | Year |
---|---|
Bronchodilator activity of xanthine derivatives substituted with functional groups at the 1- or 7-position.
Topics: Administration, Oral; Animals; Bronchial Spasm; Bronchodilator Agents; Guinea Pigs; Heart Rate; Male; Mice; Muscle Relaxation; Structure-Activity Relationship; Trachea; Xanthines | 1993 |